Skip to content
eHealthTutorial — Research Peptide Reviews
Investigational • Not FDA-approved

Pentadecapeptide research

BPC-157

BPC-157 is a synthetic 15-amino-acid peptide studied in animal injury models and laboratory cell systems. Rat tendon findings and tiny human safety observations do not establish that a research vial heals injuries or is safe for use.

Open calculator Explore the research
Generic research visual — not a commercial product
Compound typeSynthetic 15-amino-acid peptide
Evidence baseAnimal and cell work; very limited human data
Regulatory contextInvestigational / Not FDA-approved
Page purposeResearch and calculation

Compound calculator

BPC-157 reconstitution calculator

Enter the values printed on your vial and the liquid volume you added to calculate concentration, liquid volume, and the corresponding mark on a U-100 syringe scale.

Selected peptide or compoundBPC-157
Enter the total amount printed on the vial.
mL
Enter the liquid volume added in milliliters.
You provide this amount; the calculator does not select or recommend it.
Scale reference only; confirm the markings on the physical syringe.

Your BPC-157 calculation appears here

Enter the three required values to see the mathematical result.

This calculator performs arithmetic using values you enter. It does not select or recommend an amount, schedule, treatment, preparation method, or method of administration.

Research overview

What is BPC-157?

BPC-157 is a 15-residue peptide sequence used in experimental studies, sometimes called a gastric pentadecapeptide in the literature. It has been examined in different injury and tissue models. The published name and sequence do not independently verify the identity, formulation, or purity of a vial offered by any seller.

What has researchers’ attention?

A study of surgically transected rat Achilles tendons reported stronger functional, mechanical, and microscopic healing measures in BPC-157 groups than saline controls, and examined cultured tendon cells. Another paper assessed ligament injury in rats. These are controlled animal and laboratory observations, not proof of benefit in people. A very small human pilot reported no measurable adverse changes in selected short-term assessments in two participants who had previously received BPC-157, but had no control group and did not test injury-healing effectiveness. FDA has stated that safety information for proposed compounded routes is inadequate and flagged potential immunogenicity and impurity-characterization concerns.

Important limitation

Two previously exposed participants cannot establish a reliable safety profile, and rat tissue findings cannot validate treatment of human injuries. FDA’s compounding concerns include limited route-specific safety data, possible immunogenicity, and characterization of peptide-related impurities. This page provides no preparation, amount, schedule, or administration recommendation and does not validate a supplier product.

Research references

Calculation boundary

The calculator performs concentration arithmetic only when a user enters a mass and liquid volume. It does not verify identity, formulation, purity, sterility, stability, compatibility, biological-unit equivalence, or whether reconstitution applies to a particular product. Do not convert IU or other biological units to mg without an authoritative, exact-product relationship.

For research purposes only. This page is educational and is not medical or veterinary advice or a recommendation to purchase, prepare, administer, or use any product.